Study suggests role for interleukin-17A in PsA


The results of a Phase III study suggest an important role for interleukin-17A in the pathogenesis of psoriatic arthritis, investigators of an industry sponsored trial say. Published in the NEJM the randomised study of 606 patients with psoriatic arthritis found the anti–interleukin-17A monoclonal antibody secukinumab was better than placebo in improving the signs and symptoms ...


Already a member? Login to keep reading


OR
© 2017 the limbic